Kiialainen, A., Adamkewicz, J., Petry, C., Oldenburg, J., Pipe, S. W., Young, G., . . . Schmitt, C. (2024). Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks. Elsevier.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Kiialainen, Anna, et al. Pharmacokinetics and Coagulation Biomarkers in Children and Adults with Hemophilia A Receiving Emicizumab Prophylaxis Every 1, 2, or 4 Weeks. Elsevier, 2024.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Kiialainen, Anna, et al. Pharmacokinetics and Coagulation Biomarkers in Children and Adults with Hemophilia A Receiving Emicizumab Prophylaxis Every 1, 2, or 4 Weeks. Elsevier, 2024.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.